CIRM-funded building at UC Irvine receives LEED Platinum certification

Michelle Kim / University Communications

In May 2010 University of California Irvine opened their new stem cell building funded in part by CIRM. In addition to its state-of-the art research facilities designed to speed the development of stem cell therapies, the Sue & Bill Gross Hall also recently received LEED Platinum certification from the U.S. Green Building Council.

According to a press release from UCI:

Gross Hall scored points for such features as dimmable and occupancy-controlled lighting, use of energy-saving building materials, and mechanical systems that are 50 percent more efficient than required by California’s Title 24 energy code. The operable windows are tied into the heating and air-conditioning controls so that when a window is opened, mechanical ventilation of that room shuts off.

An $80 million, 100,000-square-foot structure, Gross Hall was designed to facilitate contact between patients in the first-floor clinic and rehabilitation center and stem cell researchers on the first, second and third floors. Labs are equipped with Aircuity technology that monitors indoor air quality and adjusts air-change rates based on contaminant levels.

UCI received $27 million from CIRM for the building and a $10 million from Sue & Bill Gross. The remaining funds came from donations and institutional commitments leveraged by CIRM’s investment. This is one of the 12 buildings supported through CIRM’s Major Facilities programs. The complete list of those buildings is available here. The 12 major facilities received $272 million from CIRM, with private donations and institutional investments bringing the project totals to more than $1 billion. An independent review of the impact of this investment for the state economy suggested that the projects would create 13,000 job years of employment and $100 million in tax revenue.


3 thoughts on “CIRM-funded building at UC Irvine receives LEED Platinum certification

  1. Less about designations and more about how you're going to help people…

    Stem cell trial's cancellation disappoints paraplegic patient and a Northwestern researcher
    World's first test of controversial therapy to repair spinal cords was canceled by California firm Geron
    In November, when he saw a Chicago area code flash across his cellphone, Neslund thought it was Fessler calling to update him on his latest examinations. He had recently begun to feel faint digestive sensations and wondered whether the procedure had begun to work, though doctors had told him it might take up to two years to see results.

    Instead, Fessler told Neslund that Geron had canceled its stem cell pursuits after determining it was financially riskier than focusing on its two cancer drugs. In an announcement at the time, the company disclosed that funds were low and that it would be eliminating almost 40 percent of its workforce.

    Although Geron said it would continue for the next 15 years to monitor Neslund and the other patients who had received the transplants, no one else would be enrolled.

    “I was worried,” said Neslund, who now lives in Arizona. “You have these things shot in your back and then they tell you that they ran out of money. It just doesn't seem right to me.”,0,4953119.story

  2. “Sue & Bill Gross Hall also recently received LEED Platinum certification from the U.S. Green Building Council.” This is nice, I guess.

    I'd like to see a story about the conversion of some old warehouse into a research facility as a money-saving initiative that allows more money for research.

    Looks like the program is either having trouble focusing on the core mission or it's over-funded.

  3. CIRM funded 12 stem cell research facilities in California, several of which did convert older structures into modern research facilities. Among these was UC Davis, which was the first of our major facilities to open. They have research programs focusing on several diseases, and they have a manufacturing facility that's working with groups throughout California to produce the cells that are going to be used in clinical trials.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s